Global Appendicitis Diagnostics and Treatment Market - 2021-2028
|出版日期||內容資訊||英文 180 Pages
|闌尾炎診斷及治療的全球市場(2021年∼2028年) Global Appendicitis Diagnostics and Treatment Market - 2021-2028|
|出版日期: 2021年06月22日||內容資訊: 英文 180 Pages||
The global appendicitis diagnostics and treatment market. size was valued at US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).
Appendicitis is an inflammation of the appendix, a finger-shaped pouch that projects from your colon on the lower right side of the abdomen. Appendicitis causes pain in lower right abdomen. It's a medical emergency that almost always requires surgery as soon as possible to remove the appendix. While you can live just fine without it after the surgery.
The rising prevalence of appendicitis and growing demand for diagnostic and treatment options of appendicitis will drive the growth of the Global Appendicitis Diagnostics and Treatment Market. in the forecast period. In addition, the rising incidence of pediatric appendicitis is also one of the major factors propelling the market.
The rising prevalence of appendicitis and incidence of pediatric appendicitis will drive the market growth
Appendicitis mainly occurs between the age of 5 and 45, with a mean age of 28. Thus, the incidence is approximately 233/100,000 people. Males have a slightly higher predisposition of developing acute appendicitis compared to females, with a lifetime incidence of 8.6% for men and 6.7 % for women.
The prevalence of acute appendicitis is more as compared to chronic appendicitis. One out of every 15 people will develop acute appendicitis in their lifetime. More than 250,000 appendectomies are performed each year in the U.S, however, the incidence is lower in populations where a high-fiber diet is consumed. Globally, the pooled incidence of appendicitis or appendectomy is around 100 per 100,000 person-years.
Pediatric appendicitis may occur in children with cystic fibrosis, which can have a greater risk. Having a family history of appendicitis may also increase a child's risk for this condition. It can be diagnosed with the minimally invasive technique for Transumbilical Laparoscopic Assisted Appendicectomy. Laparoscopic-assisted single-port appendectomy (SPA) has not yet evolved as the gold standard but has also been performed in children and found to be safe. Appendicitis is considered as clinical diagnosis, and imaging is beneficial in doubtful cases, such as female patients of childbearing age. Different types of equipment are involved for the diagnosis of appendicitis, such as the use of ultrasound is increasing, particularly in children in whom the risks of ionizing radiation are greatest. The advantages include decreased cost relative to other imaging modalities and lack of ionizing radiation exposure. C.T. of the abdomen and pelvis is also considered the modality of choice for definitive assessment of patients evaluated for possible appendicitis. The increasing cases of appendicitis will lead to the rise of the Global Appendicitis Diagnostics and Treatment Market.
Growing demand for diagnostic and treatment options
The evaluation and treatment of acute appendicitis remain essentially unchanged for individuals with this disease. Even though advancements have been made in laboratory analysis and imaging via ultrasonography and C.T., nothing can replace careful evaluation by an experienced surgeon.
For the diagnosis of appendicitis, practitioners should interpret laboratory evaluations in association with the patient's clinical history and physical examination findings. Although lab results may help support the clinical diagnosis, they cannot replace a good history and physical examination. The implementation of laparoscopy has revolutionized surgery over the past few years, incorporating significant benefits for the patient. Laparoscopy is a minimally invasive surgery (MIS), a revolutionary procedure that has benefitted both the patients and the doctor's.Keyhole surgery (laparoscopy) is usually the preferred method of removing the appendix because the recovery tends to be quicker than with open surgery.
Difficulty in the diagnosis of appendicitis will hamper the market
Abdominal pain is the most common reason for consultation in the emergency department, and most of the time, its cause is an episode of acute appendicitis. According to a study by Medspace statistics, reports that 1 of 5 cases of appendicitis is misdiagnosed, however, a normal appendix is found in 15-40% of patients who have an emergency appendectomy. The misdiagnosis rate of acute appendicitis is high due to the unusual presentation of the symptoms. The overall accuracy for diagnosing acute appendicitis is approximately 80%, with a false-negative appendectomy rate of 20%. Diagnostic accuracy varies by sex, with a range of 78-92% in males and 58-85% in female patients.
According to University of Washington researchers, although more diagnostic tools are available now than ever, there has been no improvement in the rate of misdiagnosis of appendicitis during the last decade.
According to the study results by the Journal of the American Medical Association, despite the availability of the new tests, in nearly one of four appendectomies performed in women of childbearing age, the removed appendix is not infected. The rate of misdiagnosis among young women and older men has increased.
COVID-19 Impact Analysis
The COVID-19 pandemic has impacted the healthcare systems globally. Acute appendicitis is the most commonly performed emergency surgery in the United States and is unlikely to improve without medical or surgical intervention. Dramatic reductions in E.D. visits prompted concern that individuals with severe conditions, such as acute appendicitis, deferred treatment for fear of contracting COVID-19. Appendicitis patient admissions in 2020 decreased throughout march into april, with april experiencing the fewest admissions. However, the incidence of acute appendicitis was slightly lower during the first wave of the 2020 COVID-19 pandemic. More patients presented with a delay and with complicated appendicitis than in a corresponding period in 2019.
The acute type appendicitis segment has dominated the market
Acute appendicitis is a widespread surgical emergency diagnosed by combining the history, examination, and investigations with building a clinical picture. Traditionally, appendectomy has been the treatment for acute appendicitis. Several diagnostic scoring systems for acute appendicitis have been described. The most commonly used are the Alvarado score and AIR-Appendicitis Inflammatory Response (Andersson) score. Both of these scoring systems can increase the diagnostic accuracy, thus guiding the decision-making and decreasing the need of potentially harmful and expensive imaging. It is the most common surgical disease with a lifetime risk of 7-8%. Although many controversies exist regarding non-operative management of AA, antibiotics play an important role in the treatment of patients with AA as demonstrated by several prospective trials and meta-analyses. Therefore, the comparison of surgery and antibiotic therapy still remains a challenging and debated issue which will drive the global appendicitis diagnostics and treatment market.
The treatment segment is expected to dominate the market
Appendicitis treatment usually involves surgery to remove the inflamed appendix. Appendectomy is the surgery done to remove the appendix. It is the standard treatment for almost all cases of appendicitis. The surgery is done by one of the following methods like laparoscopic surgery or laparotomy.In laparoscopic surgery, surgeons use several smaller incisions and special surgical tools that they feed through the incisions to remove appendix. Laparoscopic surgery leads to fewer complications, such as hospital-related infections, and has a shorter recovery time.Whereas laparotomy is used to remove the appendix through a single incision in the lower right area of your abdomen. For minimally invasive procedures laproscopy surgery is most commonly preferred.
With recent development, treatment with Robot-assisted procedures accounted for 15.1% of all general surgeries in 2018.Hospitals that rolled out robotic surgery programs saw a broad and immediate increase in such procedures and corresponding decrease in laparoscopic surgery, which is also minimally invasive.
The diagnostic segment is expected to dominate the Global Appendicitis Diagnostics and Treatment Market. in the forecast period
The symptoms of appendicitis may not be typical,further tests may be needed to confirm the diagnosis and rule out other conditions. There are different diagnostic tests available in recent times for the diagnosis of appendicitis. For example blood tests, it can show a high white blood cell count as a sign of infection. Urinalysis is also done to rule out a urinary tract infection or a kidney stone.For women, doctors may also order blood or urine samples to check for pregnancy.
Imaging test is the best diagnosis for appendicitis and other causes of pain in the abdomen.In an abdominal ultrasound, doctor uses a device, called a transducer, to bounce safe, painless sound waves off of your organs to create an image of their structure. A radiologist reviews the images, which can show signs of a blockage in your appendiceal lumen, a burst appendix, inflammation and other sources of abdominal pain
Doctors use ultrasound as the first imaging test for diagnosis of appendicitis in children, young adults, and pregnant women.An MRI(Magnetic resonance imaging) can show signs of a blockage in your appendiceal lumen, a burst appendix, inflammation and sources of abdominal pain.When diagnosing appendicitis and other sources of abdominal pain, MRI can be used as a safe, reliable alternative to a computerized tomography (C.T.) scan. C.T. scan uses x-rays and computer technology to create images. It shows an enlarged or a burst appendix, an appendiceal abscess and a blockage in appendiceal lumen.Women of childbearing age should have a pregnancy test before having a C.T. scan because the radiation from C.T. scans can be harmful to a developing fetus.
North America region dominates the Global Appendicitis Diagnostics and Treatment Market. mainly due to the growing prevalence of appendicitis and increased awareness of the disease, and the demand for effective treatment. As per research, in 2018, the incidence of acute appendicitis in the United States was 10 per 100,000 people. Appendicitis is likely to affect around 7% of the global United States population, with an incidence rate of 1.1 cases in 1,000 people every year. The lifetime risk of appendicitis is 1 in 15 in the United States. One-third of appendicitis cases present to the hospital with a perforated appendix. The healthcare expenditure in the U.S has increased from previous years, which may see accelerated growth in the medical devices industry.
According to preliminary projections from CMS' Office of the Actuary published in Health Affairs. National health care spending in the United States is expected to grow at an average annual rate of 5.4% from 2019 to 2028, outpacing the gross domestic product's (GDP) average annual growth rate of 4.3%.In the report, CMS estimated that prices for medical goods and services would grow at an average annual rate of 2.4% from 2019 to 2028 and would account for 43% of total projected growth in personal health care spending during that time.
The Global Appendicitis Diagnostics and Treatment Market. is moderately competitive with the presence of local as well as global companies. Some prominent key players in this market are Johnson & Johnson Services Inc, Pfizer Inc, Lupin, Siemens, Koninklijke Philips NV, Becton, Dickinson and Company, B. Braun Melsungen AG, Cook, Medtronic, Teva Pharmaceutical Industries Ltd, Medsinglong Co Ltd., Guangzhou Medunion Technologies Co.ltd and Guangzhou Maya Medical Equipment.Co.ltd
Key Companies to Watch
B. Braun Melsungen AG
Overview: B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. Every service that B. Braun provides incorporates the entirety of our knowledge and skills, the company's deep understanding of users' needs, and more than 180 years of extensive expertise. With its constantly growing portfolio of adequate medical care solutions, B. Braun contributes towards protecting and improving people's health. The B. Braun product range comprises 5,000 different products, 95 percent of which are manufactured by the company. In addition, by offering supplementary services and consulting, B. Braun is a system supplier that develops the best solution for patients in close partnership with our customers, making a significant contribution to medical advancements.
Product Portfolio: The Company offers effective medical care solutions and focuses on the further systematic development of the EinsteinVision 3D camera system, vessel sealing and closure instruments such as Caiman and D.S. appendectomy clips, as well as hand-held instruments.
Key Development: On Aug. 5, 2020, B. Braun Medical Inc. (B. Braun) and Kerma Medical Products, Inc. (Kerma) announced a collaboration to improve the development and delivery of healthcare products and services with an emphasis on veteran, minority and other underserved communities. The companies will work together in various areas, including product development, co-marketing opportunities, strategic sourcing, sustainable manufacturing, and diversity programs.
The Global Appendicitis Diagnostics and Treatment Market. report would provide an access to an approx. 60 market data table, 49 figures and 200 pages.
Global Appendicitis Diagnostics and Treatment Market. - By Type
Global Appendicitis Diagnostics and Treatment Market. - By Diagnosis & Treatment
Global Appendicitis Diagnostics and Treatment Market. - By End User
Global Appendicitis Diagnostics and Treatment Market. - By Region
LIST NOT EXHAUSTIVE